As of 2026-09-18, the Relative Valuation of ImmunoGen Inc (IMGN) is (7.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -122.6%.
The range of the Relative Valuation is (6.18) - (7.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.4x - 29.7x | 26.6x |
| Forward P/E multiples | 23.5x - 30.5x | 27.0x |
| Fair Price | (6.18) - (7.81) | (7.04) |
| Upside | -119.8% - -125.0% | -122.6% |
| Date | P/E |